Navigation Links
KV Pharmaceutical Company Completes Unaudited Fiscal 2007 Results; Receives Trading Extension From NYSE
Date:2/15/2008

70,778 388 (f) 71,166

Prepaid and other assets 6,963 49 (a) 7,012

Deferred tax asset 8,034 2,038 (b)(c)(f)(g) 10,072

Total current assets 347,990 1,300 349,290

Property and equipment, net 178,042 - 178,042

Intangible assets and

goodwill, net 72,955 - 72,955

Other assets 19,026 - 19,026

Total assets $618,013 $1,300 $619,313

Current liabilities:

Accounts payable $17,975 $- $17,975

Accrued liabilities 17,100 7,576 (b)(c)(d)(e) 24,676

(f)(g)

Current maturities of

long-term debt 1,681 - 1,681

Total current liabilities 36,756 7,576 44,332

Long-term debt 241,319 - 241,319

Other long-term liabilities 5,442 - 5,442

Deferred tax liabilities 25,221 - 25,221

Total liabilities 308,738 7,576 316,314

Commitments and contingencies - - -

Shareholders' equity:

Preferred stock - - -

Class A common stock 400 (3) (d) 397

Class B common stock 127 - 127

Additional paid-in capital 129,367 15,813 (b)(d) 145,180

Retained earnings 233,496 (22,086) (a)(b)(c)(e) 211,410

(f)(g)

Accumulated other

comprehensive loss (211
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States
2. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
3. NUCRYST Pharmaceuticals announces year-end results
4. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
5. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. Convera(R) Expands Advanstar OnLine Business to Vertical Search Covering Pharmaceutical Industry Applications
8. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals
9. Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation
10. MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product
11. Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , "This bill provides for an unprecedented ...alth care about if it is not for preserving and pr...t must be defeated." Charmaine Yoest ,, WASH...ns United for Life Action President and CEO Dr. Ch...enate by releasing the following statement: ,,...
(Date:11/21/2009)... NH based medical credentialing ... its industry to form a partnerhsip with Amerinet,...This partnership will help to transform quality ca... (Vocus) November 21, 2009 -- ISG Group, ...unced a new agreement with Amerinet Inc., a leadin...
(Date:11/21/2009)... Linwood Group ask whether there... be measured? , London, U...l that with up to one in three of the adult UK pop...f developing alcohol-related liver disease*, it is...ing to rehabilitation programmes and residential c...
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Followi...arket Company removed from sale Shedd,s Country Cr...e and Shedd,s Country Crock ® Side Dishes DEL... allergen. ,, The following code dates and UPC...; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, ...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewswire-... (CVSL.OB), http://www.CVSLMEDICAL.COM , a leadin...hnology, today announced that,the company,s Board ...ations,in Europe, Canada and the Far East for its ...applicable for all angioplasty (PCTA) procedures. ...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...ches new version of Infection Surveillance and Con...ONTO, Oct. 18 /PRNewswire/ - rL Solutions, the lea...tware, today announced the release of,Infection Mo...PW), running from October,14th to the 20th, is ent...
...Global Med Technologies(R),Inc. (OTC Bulletin Boar...mation technology company, announced today that it...as submitted its ElDorado Donor(TM),software for a...e FDA. ElDorado Donor is intended as a comprehens...
...Many people, including significant proportions of ...r from post-traumatic stress disorder (PTSD), ofte... While several drugs and psychotherapies are used...hat doesn,t, says a new report from the Institute ...
... N.J. A revolutionary, new biomaterial, developed... at Rutgers University, has moved from the lab ben...nt, a product of a breakthrough methodology in bio...ts are tiny tubes inserted into diseased arteries ...
...eveals heightened activity of neurotransmitter dop...s) -- Researchers have identified molecular mechan... are less vulnerable to the stress caused by diffi...he post-traumatic stress disorder suffered by troo...
...n. -- Mayo Clinic has clarified the methods of dia...-understood blood vessel disease of the brain and ...rimary central nervous system vasculitis (PCNSV) c... laboratory studies. , This disease is often susp...
Other Medicine News:Health News:Infection MonitorPro Version 1.1 Released during International Infection Prevention Week 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 3Health News:Effectiveness of most PTSD therapies is uncertain 2Health News:Effectiveness of most PTSD therapies is uncertain 3Health News:Rutgers biomaterial debuts in clinical trials of new stent 2Health News:Rutgers biomaterial debuts in clinical trials of new stent 3Health News:Vulnerability to Stress Linked to Brain Molecule 2Health News:Vulnerability to Stress Linked to Brain Molecule 3Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 2Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 3
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-F...q: BCRX ) today announced the pricing of a public...at $9.75 per share, resulting in gross proceeds of...red by BioCryst pursuant to an effective shelf reg...rities and Exchange Commission. BioCryst has also...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Binghamton Research Group Develops New Cancer Treatment 5010 1Binghamton Research Group Develops New Cancer Treatment 5010 2Binghamton Research Group Develops New Cancer Treatment 5010 3Binghamton Research Group Develops New Cancer Treatment 5010 4HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Reactive oxygens role in metastasis 9946 1Reactive oxygens role in metastasis 9946 2
...ta Selected and Presented as,Platform Presentation...Technology,Demonstrates Optimal Functional Activit...-- Discovery,Laboratories, Inc. (Nasdaq:DSCO) anno...hase 2 clinical trial of Surfaxin(r),(lucinactant ...reatment of Bronchopulmonary Dysplasia (BPD) were ...
...May 8, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG)... clinical trial for its ALTACE(R) (ramipril),diure...merican,Society of Hypertension,s Twenty-Second An...ay 19, 2007 at the Hyatt Regency Hotel,Chicago, I... for,review from 10 AM to 6 PM CDT. The Company pr...
Other Medicine Technology:Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting 2
Glucose (Liquid) Reagent
Glucose Hexokinase Reagent Set
Glucose UV Reagent
Glucose Color Reagent
Medicine Products: